Literature DB >> 1776158

Mortality of 11,500 nickel workers--extended follow up and relationship to environmental conditions.

H S Shannon1, C Walsh, N Jadon, J A Julian, J K Weglo, P G Thornhill, A G Cecutti.   

Abstract

An extended follow-up from 1977-84 was achieved in a cohort of 11,567 nickel workers engaged in mining, milling and smelting originally studied from 1950-76. Exposure data were incorporated into the analysis. One nasal cancer occurred. The lung cancer Standardized Mortality Ratio beyond 15 years from first exposure was significantly high overall (128) and in miners (153). However, detailed analyses by era of first mining and duration of mining, as well as cumulative exposure to different nickel species, did not appear consistent with an occupational etiology since significant trends were not observed. At the levels of exposure incurred, large increases in lung and nasal cancer, observed in nickel refineries elsewhere, did not occur.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776158     DOI: 10.1177/074823379100700404

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  3 in total

1.  Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers.

Authors:  A Andersen; S R Berge; A Engeland; T Norseth
Journal:  Occup Environ Med       Date:  1996-10       Impact factor: 4.402

2.  Mortality in a combined cohort of uranium enrichment workers.

Authors:  James H Yiin; Jeri L Anderson; Robert D Daniels; Stephen J Bertke; Donald A Fleming; David J Tollerud; Chih-Yu Tseng; Pi-Hsueh Chen; Kathleen M Waters
Journal:  Am J Ind Med       Date:  2016-10-18       Impact factor: 2.214

3.  New views on the hypothesis of respiratory cancer risk from soluble nickel exposure; and reconsideration of this risk's historical sources in nickel refineries.

Authors:  Philip G Thornhill; Bruce R Conard; James G Heller
Journal:  J Occup Med Toxicol       Date:  2009-08-23       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.